Adverse Events Requiring Hospitalization Following Catheter Ablation for Atrial Fibrillation in Heart Failure with versus without Systolic Dysfunction

Naoya Kataoka,Teruhiko Imamura,Takahisa Koi,Keisuke Uchida,Koichiro Kinugawa

DOI: https://doi.org/10.3390/jcdd11020035

2024-01-23

Journal of Cardiovascular Development and Disease

Abstract:Background: The safety and efficacy of atrial fibrillation (AF) ablation in individuals with heart failure (HF) with preserved ejection fraction (EF), particularly concerning the occurrence of post-procedural adverse events necessitating hospitalization, including anticoagulant-associated major bleeding, still lack conclusive determination. Methods: Data from patients with HF and AF who underwent catheter ablation for AF between 2019 and 2022 at our institution were retrospectively reviewed. All participants were divided into an EF < 50% group or an EF ≥ 50% group according to their baseline left ventricular EF. The composite incidence of the clinical events following catheter ablation was compared between the two groups: (1) all-cause death, (2) HF hospitalization, (3) stroke or systemic embolism, and (4) major bleeding. Results: A total of 122 patients (75 years old, 68 male) were included. Of them, 62 (50.8%) patients had an EF ≥ 50%. EF ≥ 50% was an independent predictor of the composite endpoint (adjusted odds ratio 6.07, 95% confidence interval 1.37–26.99, p = 0.018). The incidences of each adverse event were not significantly different between the two groups, except for a higher incidence of major bleeding in the EF ≥ 50% group (12.7% vs. 0%, p = 0.026). Conclusions: Among patients with HF coupled with AF, the incidence of adverse events following AF ablation proved notably elevated in patients with EF ≥ 50% in contrast to their counterparts with EF < 50%. This disparity primarily stems from a heightened occurrence of major bleeding within the EF ≥ 50% cohort. The strategy to reduce adverse events, especially in patients with EF ≥ 50%, remains the next concern.

cardiac & cardiovascular systems

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the incidence of adverse events and their clinical impacts in heart failure (HF) patients with preserved ejection fraction (EF) and those with reduced EF after atrial fibrillation (AF) catheter ablation. Specifically, the study focuses on the following points:

1. **Primary research objective**:
- Compare the comprehensive incidence of adverse events after catheter ablation between the EF ≥ 50% group and the EF < 50% group. These adverse events include all - cause death, hospitalization for heart failure, stroke or systemic embolism, and major bleeding.

2. **Background issues**:
- Although catheter ablation has shown positive evidence in HF patients with reduced EF, its clinical significance in HF patients with preserved EF remains controversial. In particular, the incidence and clinical impact of major bleeding events in these patients have not been clearly defined.

3. **Research hypothesis**:
- The researchers hypothesized that the incidence of major bleeding events in HF patients with preserved EF after catheter ablation may be higher than that in HF patients with reduced EF.

4. **Research methods**:
- Retrospectively analyze the clinical data of HF patients who underwent AF catheter ablation in an institution between 2019 and 2022.
- Divide the patients into the EF ≥ 50% group and the EF < 50% group according to the baseline left ventricular EF level.
- Compare the differences in the comprehensive incidence of postoperative adverse events and their individual components between the two groups.

5. **Research results**:
- A total of 122 patients were included, of which 62 (50.8%) patients had an EF ≥ 50%.
- EF ≥ 50% was an independent predictor of the composite endpoint event (adjusted odds ratio 6.07, 95% confidence interval 1.37 - 26.99, p = 0.018).
- Except for major bleeding events, there were no significant differences in the incidence of other adverse events between the two groups, but the incidence of major bleeding events in the EF ≥ 50% group was significantly higher than that in the EF < 50% group (12.7% vs. 0%, p = 0.026).

6. **Conclusion**:
- Among HF patients with AF, the incidence of adverse events after catheter ablation in patients with EF ≥ 50% is significantly higher than that in patients with EF < 50%. This is mainly due to the higher incidence of major bleeding events in the EF ≥ 50% group.
- Further research is needed to reduce adverse events, especially major bleeding events, particularly in patients with EF ≥ 50%.

Through the above - mentioned research, the paper aims to fill the current gap regarding the incidence of adverse events in HF patients with preserved EF after AF catheter ablation and provide a basis for clinical decision - making.